Search the Newsreel

Hubbell Inc. stock underperforms Thursday when compared to competitors

Hubbell Inc. (HUBB) shares fell 1.13% on Thursday, closing at $507.10, despite a generally positive trading day for the broader stock market. The S&P 500 Index rose 0.65% and the Dow Jones Industrial Average increased by 0.13%. This marks the second consecutive day of …

BBVA Argentina enters quiet period ahead of Aug. 27 results

BBVA Argentina (BBAR) has announced its Second Quarter 2026 financial results schedule, entering a quiet period from August 13 through August 27, 2026. The earnings release is set for after market close on Thursday, August 27, 2026, followed by a conference call on Friday, …

Pharmacy giant Bristol Myers Squibb to build $2.3B Houston factory

Bristol Myers Squibb has chosen Houston, Texas, as the location for its new state-of-the-art manufacturing facility. This 60,000-square-foot site represents a $2.3 billion investment and is projected to create 500 skilled jobs in Generation Park. Construction is set to begin next year, with the …

Chubb Limited Declares Quarterly Dividend, Payable on October 2, 2026

Chubb Limited's Board of Directors has declared a quarterly dividend of $1.02 per share. This dividend is payable on October 2, 2026, to shareholders who are on record as of the close of business on September 11, 2026.

Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

A federal appeals court has reinstated a $6.7 billion lawsuit against Bristol Myers Squibb, brought by UMB Bank on behalf of former Celgene shareholders. The suit alleges Bristol Myers deliberately delayed FDA approvals for three drugs, including the cancer therapy Breyanzi, to avoid payouts …

TBBB Stock Jumps As BBB Foods Delivers Big Q2 Beat

TBBB Stock Jumps As BBB Foods Blows Past Q2 Revenue Targets

The Sharpest Exchanges From ABBV’s Earnings Call

Chubb Limited Board Declares Quarterly Dividend

ZURICH, Aug. 13, 2026 /PRNewswire/ -- The Board of Directors of Chubb Limited (NYSE: CB) today declared a quarterly dividend equal to $1.02 per share, payable on October 2, 2026 to shareholders of record at the close of business on September 11, 2026. The …

Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation

Investing.com -- Wolfe Research upgraded two major pharmaceutical companies to Outperform on Thursday, citing stronger growth prospects, attractive valuations and a series of upcoming clinical catalysts. For Biogen, Wolfe raised its rating from Peer Perform and set a $300 price target, arguing that the …

Shareholders Will Receive Chubb's $1.02 Dividend on Oct. 2

Chubb Limited (NYSE: CB) has declared a quarterly dividend of $1.02 per share. This dividend is payable on October 2, 2026, to shareholders of record as of September 11, 2026. This represents the second installment of the dividend approved by shareholders on May 21, …

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …

Die Abbott-Laboratories-Aktie legt nach starken Quartalszahlen und solider Guidance zu

Wolfe Upgrades AbbVie to Outperform From Peer Perform, Price Target is $300

Wolfe has upgraded AbbVie (ABBV) to an "Outperform" rating from "Peer Perform," setting a new price target of $300. This upgrade indicates a more positive outlook on the pharmaceutical company's stock performance. The article also lists recent news and analyst actions related to AbbVie, …

Year-round Royal Caribbean sailings from Singapore to begin in October 2026

Royal Caribbean International will begin year-round sailings from Singapore starting October 2026, featuring the Navigator of the Seas. This initiative, facilitated by TIRUN Travel Marketing, aims to offer Indian travelers more diverse and flexible cruise options across Southeast Asia, including itineraries to Vietnam, Malaysia, …

Cytokinetics sues Bristol-Myers in patent case (CYTK:NASDAQ)

Cytokinetics has filed a lawsuit against Bristol-Myers Squibb and its acquisition MyoKardia. The suit aims to prevent a potential patent infringement case concerning Cytokinetics' heart disease treatment, Myqorzo (aficamten). The dispute involves U.S. Patent No. 12,616,697.

AbbVie Inc. $ABBV Shares Acquired by Mission Wealth Management LP

Mission Wealth Management LP significantly increased its stake in AbbVie Inc. (NYSE:ABBV) by 119.1% in the second quarter, now holding 69,052 shares valued at $17.4 million. This move is part of a broader trend of institutional investors and hedge funds holding 70.23% of AbbVie's …

V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT

V. M. Manning & CO. Inc. has acquired a new stake in Abbott Laboratories, purchasing 19,849 shares valued at approximately $1.8 million, making it their 11th largest holding. This move comes as Abbott Laboratories exceeded its quarterly earnings expectations and maintains a positive outlook …

McCollum Christoferson Group LLC Sells 62,644 Shares of Abbott Laboratories $ABT

Abbott India Q1 FY27 Results: Revenue Rs 1,813 Cr, PAT Rs 428 Cr and Key Highlights

Goodyear to fly 2 blimps over metro Detroit this weekend. Here's why

Goodyear will fly two blimps over metro Detroit this weekend for the first time in nearly 20 years to celebrate the Woodward Dream Cruise and the opening of a new Goodyear store. The blimps are Zeppelin NT semi-rigid airships capable of 80 mph and …

Handelsbanken Fonder AB Has $20.29 Million Stock Position in Hubbell Inc $HUBB

Handelsbanken Fonder AB reduced its stake in Hubbell Inc (NYSE:HUBB) by 7.7% in the second quarter, now holding 38,777 shares valued at $20.29 million. Other institutional investors have also adjusted their positions in Hubbell, which currently has a "Moderate Buy" consensus rating from analysts …

Abbott India Shares Fall 2.03% to Rs 27,570; Among Top Losers on Nifty Midcap 150

Abbott Laboratories $ABT Shares Acquired by DAVENPORT & Co LLC

Are Wall Street Analysts Predicting Royal Caribbean Cruises Stock Will Climb or Sink?

Royal Caribbean Group logo on ship by- sanafel via iStock With a market cap of $82.1 billion, Royal Caribbean Cruises Ltd. (RCL) is a global cruise vacation company and one of the largest players in the industry. The Miami, Florida-based company operates three wholly …

Die Bristol-Myers-Squibb-Aktie steigt nach Konsensstärke und solider Dividendenrendite

Abbott Laboratories Aktie | US0028241000 | ETR:ABL | News & Aktienkurs | FRA:ABL

Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares

Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …

ETFs Investing in RBB Bancorp Stocks

This article lists various ETFs that include RBB Bancorp stocks in their holdings. The ETFs are sorted by market value and include details such as weight, issuer, management style, focus, expense ratio, AUM, price, and NAV total return. This information aims to help investors …

Bristol Myers Squibb (BMY) Invierte En Houston Y Reabre El Debate Sobre Su Valoración

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

BBB Foods (TBBB) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, BBB Foods (TBBB) reported revenue of $1.5 billion, up 55.5% over the same period last year. EPS came in at -$0.19, compared to -$0.13 in the year-ago quarter. The reported revenue represents a surprise of +5.46% over the …

BBB Foods Chairman and CEO Converts 16 Million Class C Shares to Class A Shares

Kamal Anthony Hatoum, Chairman and CEO of BBB Foods Inc. (NYSE: TBBB), converted over 16 million Class C Common Shares to Class A Common Shares on August 7, 2026. This automatic conversion also applies to all associated vested and unvested RSUs, which will now …